The Peter Attia Drive

#251 - AMA #46: Optimizing brain health: Alzheimer's disease risk factors, APOE, prevention strategies, and more

30 snips
Apr 17, 2023
This AMA dives deep into brain health, unraveling the complexities of Alzheimer's disease diagnosis and the significance of blood-based biomarkers. Discover how APOE gene variants alter your risk and explore strategies for prevention. Beyond exercise, Peter reveals surprising factors such as nutrition, lipid management, and even oral health that impact cognitive function. Learn about the intricacies of diagnosing neurodegeneration and the role of lifestyle choices in managing risks. It’s an enlightening talk full of actionable insights!
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ADVICE

Diagnosing Alzheimer's

  • Diagnose Alzheimer's with clinical evaluation by neurologists, patient input, and cognitive tests.
  • Rule out other conditions like hypothyroidism or vitamin deficiencies with lab tests, and consider biomarkers like amyloid and tau.
INSIGHT

Alzheimer's Biomarkers

  • Alzheimer's biomarkers like amyloid and tau, measured via lumbar puncture or blood tests, help assess risk.
  • The C2N test combines APOE status, amyloid ratio, and age to predict Alzheimer's pathology, but its utility is still being evaluated.
INSIGHT

Genetic Component of Alzheimer's

  • APOE4 gene significantly increases Alzheimer's risk, but it's not deterministic; other genes modify this risk.
  • Consider whole-genome sequencing for a comprehensive understanding, as many relevant genes aren't on standard commercial tests.
Get the Snipd Podcast app to discover more snips from this episode
Get the app